Marshall Wace
TERN

Marshall Wace’s Terns Pharmaceuticals TERN Stock Holding History

Marshall Wace’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-927,600
Closed -$48.9M – 3742
2026
Q1 		$48.9M Buy
927,600
+49,017
+6% +$2.01M 0.05% 368
2025
Q4 		$35.5M Buy
+878,583
New +$20.3M 0.03% 445
2025
Q2 		– Sell
-144,644
Closed -$399K – 3168
2025
Q1 		$399K Sell
144,644
-658,692
-82% -$2.69M ﹤0.01% 2166
2024
Q4 		$4.45M Buy
803,336
+698,578
+667% +$4.73M 0.01% 1109
2024
Q3 		$874K Buy
104,758
+78,773
+303% +$648K ﹤0.01% 1699
2024
Q2 		$177K Sell
25,985
-160,024
-86% -$969K ﹤0.01% 2316
2024
Q1 		$1.22M Buy
+186,009
New +$1.21M ﹤0.01% 1575
2023
Q3 		– Sell
-356,726
Closed -$3.12M – 2673
2023
Q2 		$3.12M Buy
356,726
+171,698
+93% +$2M 0.01% 1209
2023
Q1 		$2.19M Buy
185,028
+148,947
+413% +$1.42M ﹤0.01% 1410
2022
Q4 		$367K Buy
+36,081
New +$240K ﹤0.01% 2491

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Marshall Wace's TERN Position: Q2 2026 in Review

Marshall Wace sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 927,600 shares — an estimated $48.9M sold.

Marshall Wace first reported a position in TERN in Q4 2022 and held it in 10 quarters. The position peaked at $48.9M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Marshall Wace reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 927,600 Terns Pharmaceuticals shares in Q2 2026, an estimated $48.9M.
  • Marshall Wace first reported a position in Terns Pharmaceuticals in Q4 2022 and held it in 10 quarters.
  • Marshall Wace's Terns Pharmaceuticals position peaked at $48.9M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.